Patients' Experiences Discussing Psychedelics for Therapeutic Purposes with Physicians and Other Health Care Providers.
Psychedelic medicine (New Rochelle, N.Y.) September 1, 2024 Michelle St Pierre, Lucas Standing, Yarissa Herman et al. 3 citations
A cross-sectional survey of 791 adults who use psychedelics found that 80% used them for therapeutic purposes, but only 30% of those therapeutic users had discussed this use with their physician. Barriers included stigma, perceived lack of physician knowledge about psychedelics, and legal concerns. Patients with mood disorders or posttraumatic stress disorder, and those who used ketamine, were more likely to have such discussions. The findings indicate most therapeutic psychedelic users are hesitant to talk with their doctors about it, highlighting factors that may facilitate or hinder patient-physician communication on this topic.